(NASDAQ:TCRT) ALAUNOS THERAPEUDICS INC. shares are climbing today in the pre-market up more than 31% on an astounding 36,000 trades and climbing. 

Shares are at $1.12 The company recently announced plans to present at an upcoming conference. The stock has significant pre-market volume with more than 9.751 million shares traded as of this post.

Alaunos Therapeutics to Present at the Jefferies Healthcare Conference

HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) — Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), a clinical-stage oncology-focused cell therapy company today announced that Kevin S. Boyle Sr., Chief Executive Officer and Drew Deniger, Ph.D., Vice President, Research & Development will present at the upcoming Jefferies Healthcare Conference being held on June 8-10, 2022, in New York, NY.


Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.


Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

Add New Playlist